Therapeutic Potential of Resveratrol from <i>Vitis vinifera</i> as a SIRT1 Activator in Huntington’s Disease: Insights from Proteomic Studies

Background : Huntington’s disease is a slowly progressive autosomal dominant neurodegeneration caused by mutant huntingtin-induced proteomic disturbances such as mitochondrial dysfunction, oxidative stress, protein homeostasis disturbance, synaptic degeneration, and neuroinflammation. Resveratrol, a polyphenol derived from Vitis vinifera , has emerged as a repurposed activator of Sirtuin 1 (SIRT1) with neuroprotective potential in Huntington’s disease. Aim : This manuscript aimed to evaluate the therapeutic potential of resveratrol in Huntington’s disease, with a focus on its SIRT1-mediated effects on proteomic abnormalities and related pathogenic pathways. Methods : This paper presents an analytical discussion and mechanistic analysis based on pre-clinical evidence, proteomics research, network pharmacology, and experimental studies concerning resveratrol, the SIRT1 pathway, and Huntington’s disease model systems. This manuscript combines evidence collected from experiments using iPSC-derived neurons, transgenic mice, and other neurodegeneration experiments to elucidate the molecular rationale for resveratrol repurposing. Results : According to this review, resveratrol can stimulate SIRT1 through allostery to promote mitochondrial biogenesis, antioxidant defence, autophagy, proteostasis, suppression of neuroinflammation, and recovery of synaptic and metabolic protein networks affected by Huntington’s disease. However, it is limited by poor absorption, rapid metabolism, and an inability to cross the blood-brain barrier. Major Findings : Resveratrol from Vitis vinifera appears to be a promising repurposed SIRT1 activator that may alleviate Huntington

View article page

Download PDF